Filed: 2/13/2023ACC: 0000950123-23-001941
📋 What this filing means
PATIENT SQUARE CAPITAL LP filed this quarterly 13F‑HR report disclosing 2 equity positions with a total reported market value of $236.48M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
2
Positions
$236.48M
Total AUM (reported)
323.25M
Total Shares
Allocation by class
COM$181.94M76.9%
SHS$54.54M23.1%
Portfolio Concentration
Top 3$236.48M100.0%
Top 3 weight
100.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 323.25M
Sole
Full voting authority
323.25M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole2
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings2
Rows:
EARGO INC
SOLEShares316.43M
TypeSH
Market value$181.94M
76.94%
Sole
316.43M
Shared
0.00
None
0.00
ROIVANT SCIENCES LTD
SOLEShares6.83M
TypeSH
Market value$54.54M
23.06%
Sole
6.83M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
EARGO INCSOLE | COM | 316.43M | SH | $181.94M 76.94% | 316.43M | 0.00 | 0.00 |
ROIVANT SCIENCES LTDSOLE | SHS | 6.83M | SH | $54.54M 23.06% | 6.83M | 0.00 | 0.00 |